表紙:抗炎症治療薬の世界市場レポート 2024年
市場調査レポート
商品コード
1415608

抗炎症治療薬の世界市場レポート 2024年

Anti-Inflammatory Therapeutics Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗炎症治療薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

抗炎症治療薬市場規模は近年着実に成長しています。2023年の1,098億8,000万米ドル から2024年には1,147億1,000万米ドルへと、CAGR4.4%で拡大します。実績期間の成長は 、慢性疾患の蔓延、高齢化、意識の向上、政府の取り組みに起因しています。

自己免疫疾患の有病率の増加は、今後の抗炎症治療薬市場の拡大を促進すると予想さ れます。自己免疫疾患は、通常細菌やウイルスのような有害な侵入者を防御する役割を担っている身体の免疫系が、誤って身体自身の健康な細胞や組織を標的とし、攻撃してしまう病状群を包含しています。自己免疫疾患の有病率の増加は、抗炎症治療薬の需要増加に重要な役割を果たしています。これらの治療薬は、炎症を抑え、過剰な免疫反応を調整し、これらの症状に関連する症状を緩和することを目的として、自己免疫疾患の治療に頻繁に使用されています。例えば、英国のメディア会社Guardian Media Groupが2022年1月に 報じたように、英国では自己免疫疾患に苦しむ人が400万人いると推定され、世界の増加 率は毎年3%から9%と推定されています。さらに、英国の研究大学であるオックスフォード大学が2023年5月に発表したデータによると、自己免疫疾患は世界人口の10%に影響を 及ぼすといわれています。その結果、自己免疫疾患の有病率の上昇が抗炎症治療薬市場の成長の原動力となっています。

2023年の抗炎症治療薬市場で最大の地域は北米です。欧州は予測期間中に最も急成長 する地域と予想されます。抗炎症治療薬レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の抗炎症治療薬市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の抗炎症治療薬市場規模実績と成長、2018~2023年
  • 世界の抗炎症治療薬市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の抗炎症治療薬市場、薬剤クラス別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 非ステロイド性抗炎症薬(NSAID)
  • コルチコステロイド
  • 抗炎症性生物製剤
  • 世界の抗炎症治療薬市場、適応症別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 関節炎
  • 呼吸器疾患
  • 多発性硬化症
  • 乾癬
  • 炎症性腸疾患
  • その他の炎症性疾患
  • 世界の抗炎症治療薬市場、流通チャネル別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 小売薬局
  • 病院薬局
  • オンライン配信

第7章 地域と国の分析

  • 世界の抗炎症治療薬市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の抗炎症治療薬市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 抗炎症治療薬市場の競合情勢
  • 抗炎症治療薬市場の企業プロファイル
    • Pfizer Inc.
    • Johnson and Johnson Limited
    • F. Hoffmann-La Roche Ltd.
    • Merck and Co. Inc.
    • AbbVie Inc.

第31章 その他の主要と革新的な企業

  • Bayer AG
  • Novartis AG
  • Sanofi-Aventis LLC.
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC
  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Co Ltd.
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Biogen Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r12207

“Anti-Inflammatory Therapeutics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-inflammatory therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-inflammatory therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The anti-inflammatory therapeutics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Anti-Inflammatory Biologics
  • 2) By Indication: Arthritis; Respiratory Diseases; Multiple Sclerosis; Psoriasis; Inflammatory Bowel Diseases; Other Inflammatory Diseases
  • 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Distribution
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; F. Hoffmann-La Roche Ltd.; Merck and Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Anti-inflammatory therapeutics are prescription drugs designed to address pain, reduce inflammation, and lower elevated body temperatures. They function as modifiers of the body's immune response and are essential in the management of both acute and chronic conditions such as headaches, painful episodes, as well as sprains and strains.

The primary categories of drug classes used in anti-inflammatory therapeutics encompass nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and anti-inflammatory biologics. Nonsteroidal anti-inflammatory drugs are analgesic medications without opioids that are commonly employed by individuals to alleviate mild physical discomfort. These medications find diverse applications in conditions like arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel diseases, and more. They are available through a range of distribution channels, including retail pharmacies, hospital pharmacies, and online retail platforms.

The anti-inflammatory therapeutics market research report is one of a series of new reports from The Business Research Company that provides anti-inflammatory therapeutics market statistics, including anti-inflammatory therapeutics industry global market size, regional shares, competitors with an anti-inflammatory therapeutics market share, detailed anti-inflammatory therapeutics market segments, market trends and opportunities and any further data you may need to thrive in the anti-inflammatory therapeutics industry. These anti-inflammatory therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-inflammatory therapeutics market size has grown steadily in recent years. It will grow from $109.88 billion in 2023 to $114.71 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, increased awareness, and government initiatives.

The anti-inflammatory therapeutics market size is expected to see steady growth in the next few years. It will grow to $135.6 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to innovative therapies, increasing healthcare expenditure, focus on rare diseases, biologics and biosimilars. Major trends in the forecast period include advancements in immunotherapy, artificial intelligence (AI) and machine learning (ML) in drug discovery, expansion of indications.

The growing incidence of inflammatory bowel disease is set to drive the expansion of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation in the gastrointestinal tract. Anti-inflammatory therapeutics play a pivotal role in the treatment of conditions like Crohn's disease, as they help reduce inflammation, manage symptoms, and lower the likelihood of surgery. For example, a July 2023 report from Oxford University Press (OUP), the university press of the University of Oxford, indicates that IBD has an incidence of 10.9 per 100,000 person-years and a prevalence of 721 per 100,000 people. Consequently, the rising prevalence of inflammatory bowel disease is a significant driver of growth in the anti-inflammatory therapeutics market.

The rising incidence of drug-related side effects poses a challenge and may impede the growth of the market in the foreseeable future. Anti-inflammatory therapeutics like ibuprofen can lead to side effects due to the intricate nature of inflammatory signaling pathways and the potential for exacerbating inflammation under specific circumstances. For example, as of August 2022, according to Drugs.com, a US-based online drug reference, approximately 4% to 16% of individuals using ibuprofen tablets reported experiencing at least one gastrointestinal side effect. Hence, the increasing occurrence of drug side effects is a factor restraining the growth of the anti-inflammatory therapeutics market in the coming years.

The increasing prevalence of autoimmune disorders is expected to drive the expansion of the anti-inflammatory therapeutics market in the future. Autoimmune disorders encompass a group of medical conditions where the body's immune system, typically responsible for defending against harmful invaders like bacteria and viruses, erroneously targets and attacks the body's own healthy cells and tissues. The growing prevalence of autoimmune disorders plays a significant role in the increasing demand for anti-inflammatory therapeutics. These therapeutics are frequently employed in the treatment of autoimmune disorders, aiming to reduce inflammation, regulate the overactive immune response, and alleviate the symptoms associated with these conditions. For instance, as reported in January 2022 by the Guardian Media Group, a UK-based media company, it is anticipated that there will be 4 million people in the UK suffering from autoimmune disorders, with a global increase estimated at 3% to 9% annually. Additionally, data from May 2023 from the University of Oxford, a UK-based research university, indicates that autoimmune disorders affect 10% of the world's population. Consequently, the rising prevalence of autoimmune disorders is a driving force behind the growth of the anti-inflammatory therapeutics market.

Prominent companies within the anti-inflammatory therapeutics market are actively introducing innovative drugs as a strategy to enhance their market presence. As an example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, jointly introduced Kevzara (sarilumab). This represents the first and only anti-inflammatory biologic designed for adult patients dealing with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition. It is particularly targeted at individuals who either do not respond adequately to corticosteroids or cannot tolerate corticosteroid tapering.

In March 2022, Pfizer Inc., a US-based biopharmaceutical company, completed a $6.7 billion acquisition of Arena Pharmaceuticals. This strategic move by Pfizer is intended to enhance its portfolio in the field of inflammation and immunology therapeutics, with a focus on conditions such as ulcerative colitis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. Arena Pharmaceuticals, a US-based company, specializes in the development of diverse anti-inflammatory drugs for the treatment of various immuno-inflammatory disorders.

Major players in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

North America was the largest region in the anti-inflammatory therapeutics market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anti-inflammatory therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-inflammatory therapeutics market consists of sales of Ibuprofen, naproxen, and diclofenac. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Anti-Inflammatory Therapeutics Market Characteristics

3. Anti-Inflammatory Therapeutics Market Trends And Strategies

4. Anti-Inflammatory Therapeutics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Anti-Inflammatory Therapeutics Market Size and Growth

  • 5.1. Global Anti-Inflammatory Therapeutics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Anti-Inflammatory Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Anti-Inflammatory Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Anti-Inflammatory Therapeutics Market Segmentation

  • 6.1. Global Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Anti-Inflammatory Biologics
  • 6.2. Global Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Arthritis
  • Respiratory Diseases
  • Multiple Sclerosis
  • Psoriasis
  • Inflammatory Bowel Diseases
  • Other Inflammatory Diseases
  • 6.3. Global Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Distribution

7. Anti-Inflammatory Therapeutics Market Regional And Country Analysis

  • 7.1. Global Anti-Inflammatory Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Anti-Inflammatory Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Anti-Inflammatory Therapeutics Market

  • 8.1. Asia-Pacific Anti-Inflammatory Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Anti-Inflammatory Therapeutics Market

  • 9.1. China Anti-Inflammatory Therapeutics Market Overview
  • 9.2. China Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Anti-Inflammatory Therapeutics Market

  • 10.1. India Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Anti-Inflammatory Therapeutics Market

  • 11.1. Japan Anti-Inflammatory Therapeutics Market Overview
  • 11.2. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Anti-Inflammatory Therapeutics Market

  • 12.1. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Anti-Inflammatory Therapeutics Market

  • 13.1. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Anti-Inflammatory Therapeutics Market

  • 14.1. South Korea Anti-Inflammatory Therapeutics Market Overview
  • 14.2. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Anti-Inflammatory Therapeutics Market

  • 15.1. Western Europe Anti-Inflammatory Therapeutics Market Overview
  • 15.2. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Anti-Inflammatory Therapeutics Market

  • 16.1. UK Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Anti-Inflammatory Therapeutics Market

  • 17.1. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Anti-Inflammatory Therapeutics Market

  • 18.1. France Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Anti-Inflammatory Therapeutics Market

  • 19.1. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Anti-Inflammatory Therapeutics Market

  • 20.1. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Anti-Inflammatory Therapeutics Market

  • 21.1. Eastern Europe Anti-Inflammatory Therapeutics Market Overview
  • 21.2. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Anti-Inflammatory Therapeutics Market

  • 22.1. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Anti-Inflammatory Therapeutics Market

  • 23.1. North America Anti-Inflammatory Therapeutics Market Overview
  • 23.2. North America Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Anti-Inflammatory Therapeutics Market

  • 24.1. USA Anti-Inflammatory Therapeutics Market Overview
  • 24.2. USA Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Anti-Inflammatory Therapeutics Market

  • 25.1. Canada Anti-Inflammatory Therapeutics Market Overview
  • 25.2. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Anti-Inflammatory Therapeutics Market

  • 26.1. South America Anti-Inflammatory Therapeutics Market Overview
  • 26.2. South America Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Anti-Inflammatory Therapeutics Market

  • 27.1. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Anti-Inflammatory Therapeutics Market

  • 28.1. Middle East Anti-Inflammatory Therapeutics Market Overview
  • 28.2. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Anti-Inflammatory Therapeutics Market

  • 29.1. Africa Anti-Inflammatory Therapeutics Market Overview
  • 29.2. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Anti-Inflammatory Therapeutics Market Competitive Landscape And Company Profiles

  • 30.1. Anti-Inflammatory Therapeutics Market Competitive Landscape
  • 30.2. Anti-Inflammatory Therapeutics Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck and Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Anti-Inflammatory Therapeutics Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Novartis AG
  • 31.3. Sanofi-Aventis LLC.
  • 31.4. Bristol-Myers Squibb Company
  • 31.5. AstraZeneca PLC
  • 31.6. GlaxoSmithKline plc.
  • 31.7. Takeda Pharmaceutical Company Limited
  • 31.8. Eli Lilly and Co Ltd.
  • 31.9. Amgen Inc.
  • 31.10. Boehringer Ingelheim International GmbH
  • 31.11. Viatris Inc.
  • 31.12. Teva Pharmaceutical Industries Ltd.
  • 31.13. Regeneron Pharmaceuticals Inc.
  • 31.14. Astellas Pharma Inc.
  • 31.15. Biogen Inc.

32. Global Anti-Inflammatory Therapeutics Market Competitive Benchmarking

33. Global Anti-Inflammatory Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Anti-Inflammatory Therapeutics Market

35. Anti-Inflammatory Therapeutics Market Future Outlook and Potential Analysis

  • 35.1 Anti-Inflammatory Therapeutics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Anti-Inflammatory Therapeutics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Anti-Inflammatory Therapeutics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer